NIH-funded research R21 grant

Detecting Sjögren’s Disease and Sicca Syndrome through saliva testing

Official title: Saliva Anti-SSA/Ro and Anti-SSB/La for Early Detection of Sjögren’s and SICCA Syndromes

Funded at University of California Los Angeles · NIH-11055238 · Data updated 2026-11-12

This study is working on a new saliva test to help find Sjögren’s Disease and its early signs more easily, so people can get the right treatment sooner without needing a blood test.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of California Los Angeles
NIH-funded
Lab location1 site (Los Angeles, United States)
Project startSeptember 16, 2024
Project endAugust 31, 2026
Funding year2024
Award (this year)$260,375
NIH project number1R21DE033901-01A1
Project IDNIH-11055238 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals experiencing symptoms of Sjögren’s Disease or Sicca Syndrome, particularly those who have not yet received a definitive diagnosis.

Less likely to help

Patients who have already been diagnosed with Sjögren’s Disease or Sicca Syndrome may not benefit directly from this research.

What this research studies

This research focuses on developing a saliva-based test to detect Sjögren’s Disease (SjD) and its precursor, autoimmune-Sicca Syndrome (AI-Sicca), which are often misdiagnosed or diagnosed late. The study utilizes an innovative electrochemical assay called electric field-induced release and measurement (EFIRM) to identify specific autoantibodies in saliva, providing a non-invasive alternative to traditional blood tests. By analyzing saliva samples, the research aims to improve early detection and risk assessment for these autoimmune conditions, potentially leading to timely treatment for patients.

Why it matters

Potential benefit: If successful, this research could lead to earlier diagnosis and better management of Sjögren’s Disease and Sicca Syndrome, improving patient outcomes.

How similar studies have gone: Preliminary data suggests that similar saliva-based testing approaches have shown promise in detecting Sjögren’s Disease, indicating potential for success in this research.

Where this research is happening

  • University of California Los Angeles
    Los Angeles, United States
    Active

Researchers

  • Principal investigator: Wong, David T — University of California Los Angeles
  • Study coordinator: Wong, David T

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.